LON:ABC Abcam - ABC Share Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Abcam plc Please log in to your account or sign up in order to add this asset to your watchlist. GBX 1,226 +123.00 (+11.15%) (As of 12/13/2022) Add Compare Share Share Today's Range 1,115▼ 1,25950-Day Range 1,121▼ 1,45452-Week Range 1,013.57▼ 1,760Volume6.37 million shsAverage Volume392,791 shsMarket Capitalization£2.81 billionP/E Ratio20,433.33Dividend Yield0.91%Price TargetGBX 1,462.50 ProfileAnalyst RatingsChartCompetitorsInsider TradesHeadlinesOptions Chain Abcam MarketRank™ ForecastAnalyst RatingHold2.25 Rating ScoreUpside/Downside19.3% UpsideGBX 1,462.50 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.25Based on 6 Articles This WeekInsider TradingSelling Shares£25.64 M Sold Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.20 out of 5 stars 2.1 Analyst's Opinion Consensus RatingAbcam has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 1 buy rating, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of GBX 1,462.50, Abcam has a forecasted upside of 19.3% from its current price of GBX 1,226.Amount of Analyst CoverageAbcam has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for ABC. Previous Next 0.0 Dividend Strength Dividend YieldAbcam has a dividend yield of 0.91%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthAbcam does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ABC. Previous Next 2.4 News and Social Media Coverage News SentimentAbcam has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Abcam this week, compared to 4 articles on an average week.Search Interest31 people have searched for ABC on MarketBeat in the last 30 days. This is an increase of 29% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Abcam insiders have sold more of their company's stock than they have bought. Specifically, they have bought GBX 0 in company stock and sold £256,415.04 in company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Abcam is 20,433.33, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 144.52.Price to Earnings Ratio vs. SectorThe P/E ratio of Abcam is 20,433.33, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 166.42.Price to Earnings Growth RatioAbcam has a PEG Ratio of 1.57. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioAbcam has a P/B Ratio of 3.85. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Abcam (LON:ABC) StockAbcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.Read More Receive ABC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter. Email Address ABC Stock News HeadlinesFebruary 2, 2023 | marketwatch.comEpigenetic Market Global Outlook, and Forecast 2023 To 2028|Illumina,Qiagen,AbcamJanuary 31, 2023 | marketwatch.comAntibody Services Market Analysis by 2029 with Key Players ThermoFisher, GenScript, Abcam, MBSFebruary 4, 2023 | Wall Street Watch Dogs (Ad)“Future Fuel” will unleash $11 trillion wave of wealthThe next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…January 30, 2023 | finance.yahoo.comGenomics market size to increase by USD 18,244.34 million: Analysis of major players as well as the key contributor region - TechnavioJanuary 30, 2023 | marketwatch.comAbcam Down 14%; 2022 Sales Were About GBP360MJanuary 30, 2023 | technews.tmcnet.comABCAM PLC: Trading UpdateJanuary 28, 2023 | marketwatch.comGlobal Antigen ELISA Kit Market Size 2023 Research Report by Corporation Information, Distributors Profiles, Market Share and Forecast to 2028January 27, 2023 | marketwatch.comTotal Amino Acid Assay Kit Market Opportunities, Size, Share, Emerging Trends, And Forecast To 2028February 4, 2023 | Wall Street Watch Dogs (Ad)A gold storm is coming…“We are in the early stages of a mania – the calm before the storm.”...January 25, 2023 | marketwatch.comAnnexin V Apoptosis Detection Kit Market 2023 : Industry Scenario, Strategies, Growth Factors and Forecast to 2028January 25, 2023 | bizjournals.comWaltham life sciences complex sells for nearly $600MJanuary 24, 2023 | marketwatch.comLife Science Products Market Size, Trends, Share, Growth Status, and Forecast 2028 with Top Countries DataJanuary 24, 2023 | marketwatch.comSingleplex Immunoassay Market 2023 : Projections and Regional Outlook, Key Players, Analysis, Size, Share, Growth, Trends and Forecast to 2028January 24, 2023 | marketwatch.comGlobal 384-Well Microplates Market Size Growth Rate Analysis 2023 by Marketing Channel, Distributors, Market Restraints and Forecast to 2028January 24, 2023 | marketwatch.comNT-proBNP Test Kit Market Trends, Business Overview, Industry Growth, and Forecast 2023 To 2029January 23, 2023 | marketwatch.com384-Well Microplates Market Latest Trends, Industry Size and Future Prospects 2028January 23, 2023 | marketwatch.comH-FABP Test Kit Market : Overview, Industry Trends, Analysis Key Players, Share, Size and Report 2023 to 2029January 23, 2023 | nz.finance.yahoo.com$3.68+ Billion Worldwide Immunofluorescence Assay Industry to 2031 - Increasing Prevalence of Chronic Diseases is Significantly Driving GrowthJanuary 23, 2023 | marketwatch.comG-Protein Coupled Receptor (GPCR) Targeting Market 2023 Size Report by Manufactures, Growth Rate, and Forecast 2084January 21, 2023 | marketwatch.comExclusive Verbascoside Market [2023-2028] Research Report | Industry is Booming Globally at a Significant Growth | Top Countries DataJanuary 20, 2023 | marketwatch.comLatest Insights on Global Fumonisin B1 Market [2023-2028] | Worldwide Industry Growing at a Significant Growth Rate | Top Countries DataJanuary 20, 2023 | marketwatch.comIGY Polyclonal Antibodies Market Size 2023 to Increase at 11.1% CAGR Between Forecast Years 2023 and 2027| 107 Report PagesJanuary 19, 2023 | marketwatch.comGlobal Triciribine Market is Booming Worldwide Throughout 2023 to 2028 | Share, Size, Growth | Top Countries DataJanuary 19, 2023 | marketwatch.comAntibody Testing Market Market Size 2023 Industry Analysis, Key Players, Regional Demand, Opportunity and Forecast 2029January 18, 2023 | marketwatch.comNrf2 Pathway Activators Market Analysis by 2029 with Key Players Reata Pharmaceuticals, Cayman Chemical Company, Biophore, AbcamJanuary 18, 2023 | marketwatch.comWortmannin Market is Dazzling Worldwide | Latest Research Report, Analysis, Recent Trends and Regional Growth Forecast by 2028January 18, 2023 | marketwatch.comGlobal Ebselen Market Size in 2023 | Industry Analysis by Trends, Share, Company Overview, Growth | Top Countries DataSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive ABC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:ABC CUSIPN/A CIKN/A Webwww.abcam.com Phone+44-1223-696000FaxN/AEmployees1,650Year FoundedN/APrice Target and Rating Average Stock Price ForecastGBX 1,462.50 High Stock Price ForecastGBX 1,700 Low Stock Price ForecastGBX 1,250 Forecasted Upside/Downside+19.3%Consensus RatingHold Rating Score (0-4)2.25 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio20,433.33 Forward P/E Ratio33.28 P/E Growth1.57Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio31.60 Current Ratio1.27 Quick Ratio0.89 Sales & Book Value Annual Sales£350.40 million Price / Sales8.02 Cash FlowGBX 50.93 per share Price / Cash Flow24.07 Book ValueGBX 318.30 per share Price / Book3.85Miscellaneous Outstanding Shares229,272,000Free FloatN/AMarket Cap£2.81 billion OptionableOptionable BetaN/A Key ExecutivesMr. Alan Thomas Hirzel BS (Age 54)M.B.A., M.S., MBA, MS, CEO & Exec. Director Comp: $1.23MMr. Michael Shaun Baldock B.A. (Age 58)CFO & Director Comp: $881.14kMr. Mark DermodyInterim CIOJames StaveleyVP of Investor RelationsMarc PerkinsGen. Counsel & Company Sec.Emma SceatsSr. VP of Sales, Service & Bus. Devel.Mr. Nick SkinnerSr. VP of HRMr. Mark BushfieldSr. VP of Research & InnovationMs. Kirstie Speck BBusScHead of Consumer InsightsMs. Yvonne ChienSr. VP of Customer ExperienceMore ExecutivesKey CompetitorsBTGLON:BTGOxford Nanopore TechnologiesLON:ONTGenusLON:GNSUDG HealthcareLON:UDGIndiviorLON:INDVView All CompetitorsInsiders & InstitutionsMichael BaldockSold 18,032 sharesTotal: £25.64 M ($1,422.00/share)Mara G AspinallBought 3,037 shares on 4/4/2022Total: £4.36 M ($1,436.00/share)Michael BaldockBought 5,910 shares on 3/16/2022Total: £10.05 M ($1,700.00/share)View All Insider Transactions ABC Stock - Frequently Asked Questions Should I buy or sell Abcam stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Abcam in the last twelve months. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ABC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ABC, but not buy additional shares or sell existing shares. View ABC analyst ratings or view top-rated stocks. What is Abcam's stock price forecast for 2023? 4 brokerages have issued 12-month price targets for Abcam's stock. Their ABC share price forecasts range from GBX 1,250 to GBX 1,700. On average, they anticipate the company's share price to reach GBX 1,462.50 in the next year. This suggests a possible upside of 19.3% from the stock's current price. View analysts price targets for ABC or view top-rated stocks among Wall Street analysts. How have ABC shares performed in 2023? Abcam's stock was trading at GBX 1,226 at the beginning of the year. Since then, ABC shares have increased by 0.0% and is now trading at GBX 1,226. View the best growth stocks for 2023 here. What other stocks do shareholders of Abcam own? Based on aggregate information from My MarketBeat watchlists, some companies that other Abcam investors own include Hawkins (HWKN), CA (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), HSBC (HSBA), Royal Dutch Shell (RDSA) and Centrica (CNA). What is Abcam's stock symbol? Abcam trades on the London Stock Exchange (LON) under the ticker symbol "ABC." How do I buy shares of Abcam? Shares of ABC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Abcam's stock price today? One share of ABC stock can currently be purchased for approximately GBX 1,226. How much money does Abcam make? Abcam (LON:ABC) has a market capitalization of £2.81 billion and generates £350.40 million in revenue each year. How many employees does Abcam have? The company employs 1,650 workers across the globe. How can I contact Abcam? Abcam's mailing address is 330 Cambridge Science Park, CAMBRIDGE, CB4 0FL, United Kingdom. The official website for the company is www.abcam.com. The company can be reached via phone at +44-1223-696000. This page (LON:ABC) was last updated on 2/4/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.